Carcinosarcoma: Clinical Trials

4 trials for Carcinosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4
Phase 12Terminated 2

Follow Carcinosarcoma: new trials by email Literature Review of Carcinosarcoma trials Research Report on Carcinosarcoma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
INCB099280, axitinib - Advanced Solid Tumors
Phase 1 / Phase 2TerminatedIncyte Corporation52024-04-162026-06-04
A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes
Rucaparib - Solid Tumor
Phase 2Terminatedpharmaand GmbH832020-01-162023-10-02
A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors
Rebastinib, Paclitaxel - Locally Advanced or Metastatic Solid Tumor
Phase 1 / Phase 2TerminatedDeciphera Pharmaceuticals, LLC1772018-10-252024-12-27
Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy
Carboplatin, Cisplatin, Paclitaxel - Uterine Neoplasms
Phase 2TerminatedM.D. Anderson Cancer Center42002-02-012011-09-15

Narrower conditions

Ovarian Neoplasms (3)  ·  Breast Neoplasms (2)  ·  Endometrial Neoplasms (2)  ·  Fallopian Tube Neoplasms (2)  ·  Neoplasm Metastasis (2)  ·  Uterine Cervical Neoplasms (2)  ·  Uterine Neoplasms (2)  ·  Adenocarcinoma, Mucinous (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Cystadenocarcinoma, Serous (1)  ·  Esophageal Neoplasms (1)  ·  Leiomyosarcoma (1)  ·  Lung Neoplasms (1)

Broader conditions

Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases (4)  ·  Genital Diseases, Female (4)  ·  Genital Neoplasms, Female (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms by Site (4)  ·  Neoplasms, Complex and Mixed (4)  ·  Neoplasms, Connective and Soft Tissue (4)  ·  Urogenital Diseases (4)  ·  Urogenital Neoplasms (4)  ·  Uterine Diseases (4)  ·  Adnexal Diseases (3)  ·  Endocrine Gland Neoplasms (3)

Interventions

Paclitaxel (2)  ·  Axitinib (1)  ·  Carboplatin (1)  ·  Cisplatin (1)  ·  DCC-2036 (1)  ·  rebastinib (1)  ·  rucaparib (1)

Sponsors

Deciphera Pharmaceuticals, LLC (1)  ·  Incyte Corporation (1)  ·  M.D. Anderson Cancer Center (1)  ·  pharmaand GmbH (1)

Countries

United States (3)  ·  United Kingdom (1)

Top investigators

Kim Reiss-Binder, MD (1)  ·  Lois M. Ramondetta, MD (1)  ·  Philomena Colucci (1)

Results publications

PMID 40632975

NIH funding

2023 (1)